Sun Pharma launches FluGuard for covid treatment at rs.35 per tablet.
Sun Pharma has launched Favipiravir at Rs 35 per tablet for the potential treatment of patients who have been facing mild to moderate symptoms of Covid-19 disease. It would be the cheapest in the market. The company has put a brand name FluGuard to it. Favipiravir is the oral anti-viral treatment approved in India.
As there is an immediate need to provide more treatment options to COVID-19 patients in an alarming situation, the need is felt. The drug is now available to more and more patients, thereby reducing their financial burden.